Information Notice No. 91-02: Brachytherapy Source Management
UNITED STATES
NUCLEAR REGULATORY COMMISSION
OFFICE OF NUCLEAR MATERIALS SAFETY AND SAFEGUARDS
WASHINGTON, D.C. 20555
January 7, 1991
Information Notice No. 91-02: BRACHYTHERAPY SOURCE MANAGEMENT
Addressees:
All Nuclear Regulatory Commission (NRC) medical licensees authorized to use
byproduct material for medical purposes.
Purpose:
This information notice is intended to emphasize to medical use licensees
the potential radiation hazards resulting from improper handling of
brachytherapy sealed sources. Licensees are expected to review this
information for applicability to their radioactive sealed source procedures,
distribute the notice to those responsible for radiation safety and quality
assurance, and consider actions, if warranted, to establish procedures to
prevent similar problems from occurring at their facilities. However,
suggestions contained in this notice do not constitute any new NRC
requirements, and no written response is required.
Description of Circumstances:
The following cases are recent events reported to NRC that have resulted in
unintended radiation doses to humans as a result of improper handling of
radioactive sealed sources:
Case 1: On December 14, 1989, during preparation for a brachytherapy
procedure, the medical physicist noted that there were only two sources
present within the source storage safe drawer, instead of the expected three
sources. The missing source contained 53 millicuries of cesium-137. The
Radiation Safety Officer was notified, and together with the physicist, made
a physical search and radiation survey of the area. Radiation surveys were
performed with a Geiger Mueller meter and a gamma scintillation detector.
The search and survey were expanded to the remainder of the facility, but
the source was not found. After a review of the brachytherapy source
inventory records, it was determined that the source had not been returned
to the source storage safe after completion of a brachytherapy procedure on
October 19, 1989. The root cause of the loss of the source was the failure
to return all brachytherapy sources to the source storage area promptly
after removal from the patient, and failure to document that transfer
procedure. A contributing factor was the white color of some sources, which
are easy to lose among white linens, paper, and debris. At this facility,
all sealed sources are color-coded according to their nominal activity. For
example, 20-mg sources are color-coded in white.
9012280297
.
IN 91-02
January 7 1991
Page 2 of 4
The licensee speculated that the 20-mg (white) source may have been mistaken
for cut pieces of white nylon spacers, and may have been inadvertently
placed in normal trash. The licensee failed to perform radiation surveys of
disposable waste material at the completion of the October 19, 1989
procedure. Personnel monitoring devices did not indicate unusual levels of
radiation exposure, although one technologist who was involved in the
October procedure did not wear the required ring badge. Since no
information exists to document who came into contact with the source, or for
how long, additional dose estimates would be unreliable. In conclusion, the
source is probably in a local landfill, and if there, is buried in an active
burial area and is approximately 25-40 feet below the surface.
Case 2: A patient to receiving an endobronchial iridium-192 treatment
received an unintended therapy dose to the face. The misadministration
occurred when a nylon ribbon, containing 25 seeds of 3.5 millicuries each of
iridium-192, was inserted via a catheter into the patient's bronchi. The
nylon ribbon became completely dislodged from the catheter, was expelled
outside of the lung, and came to rest next to the patient's face. The
catheter remained in place in the lung. The duty nurse noticed the dislodged
source at approximately midnight, but took no action at that time. At 2:00
a.m. that same night, the duty nurse, using bare hands, taped the end of the
ribbon containing the iridium-192 seeds to the left side of the patient's
face. At approximately 4:15 a.m., the charge nurse, while attending the
patient, noticed the dislodged source. The charge nurse called the
Radiation Safety Officer, who directed the removal of the ribbon, using a
remote handling tool. The sources were removed from the patient, and placed
in a shielded container. The estimated dose to the patient was: 1,032 rem
to a portion of the left side of the face, 282 rem to the eyes, and 357 rem
to the scalp (at one point the patient had folded the ribbon back into her
hair). The duty nurse received an estimated 17.6 rem to her hands. In
addition to the source becoming dislodged, the cause of this event was the
inappropriate response of the duty nurse to the dislodged source. The root
cause is the failure of the licensee to provide radiation safety instruction
to all personnel caring for a patient undergoing implant therapy.
Corrective actions undertaken included: removing the duty nurse from the
care of patients receiving brachytherapy implant therapy until additional
training has been completed, and a written examination of personnel, after
training, that requires an 80% passing score. In addition, the catheter
that contains the iridium-192 seeds will be crimped to prevent the seeds
from leaving the catheter.
Case 3: A total of seven seeds in nylon ribbon, each containing 7.2
millicuries of iridium-192, were acquired to be used in the treatment of a
patient with lung cancer. It was decided that only five of the seven seeds
would be needed to deliver the prescribed dose. On July 5, 1990, the ribbon
was cut into two pieces. The two ribbons, one containing two seeds, and the
other containing five seeds, were placed in a storage/transport container
and taken to the patient's room. The five seed ribbon was implanted into
the patient and
.
IN 91-02
January 7 1991
Page 3 of 4
explanted 10 hours later. The two seed ribbon was left in the storage
container in the patient's room during the 10-hour treatment period. At the
time of source removal, the radiation therapy physician counted the seeds
removed from the patient and verified that it matched the number of seeds
implanted. At the completion of the explantation procedure, a radiation
survey of the patient's room was conducted, and showed no detectable
radiation above background. On July 27, 1990, an inventory of the seeds, in
preparation for their return to the supplier, revealed that the ribbon
containing two seeds was missing. A search revealed the two seeds within a
crack between the carpeting and the wall, in the patient's room where the
July 5th brachytherapy procedure took place. It is assumed that the seeds
were pushed into the crack when the room was vacuumed, after the patient was
released on July 6, 1990. The seeds remained in the room for 22 days before
being recovered. The room remained empty until July 26, 1990, when another
patient was admitted to the room. The patient and his wife remained in the
room for the next 15 hours, at which time the sources were found and
removed. The cause of this incident was the failure to promptly conduct a
source inventory, after removing them from the patient, as described in 10
CFR 35.406. Documenting the return of the sources as required would have
made it obvious that not all the sources that had been removed from storage
had been returned.
Licensees are reminded of the importance of ensuring the safe performance of
licensed activities in accordance with NRC regulations, requirements of
their licenses, and accepted medical practice. Sealed sources for
therapeutic use are capable of delivering significant unintended exposures
to patients, health care workers, and members of the general public, when
source management procedures are not followed. The lost sources in Cases 1
and 3 may have caused significant unintended exposure to a number of people
during the time they were out of the licensees' control.
In view of these and other recent incidents involving mismanagement of
brachytherapy sources, licensees are reminded of their responsibilities to:
1. Provide radiation safety instruction to all personnel caring for the
patient undergoing implant therapy, and ensure that the instructions
meet the requirements of 10 CFR 35.410.
2. Maintain a record log for brachytherapy source use, that includes the
names of individuals properly trained, instructed, and permitted to
handle the sources as described in 10 CFR 35.406(b)(1).
3. Immediately after implanting the sources in a patient, make a radiation
survey of the patient and the area of use to confirm that no sources
have been misplaced. A record shall be made of each survey as
described in 10 CFR 35.406(c).
.
IN 91-02
January 7 1991
Page 4 of 4
4. After the sources are removed from the patient, conduct a radiation
survey of the patient to confirm that all sources have been removed as
required in 10 CFR 35.404(a), and survey the area of use, to include
linens, disposables, and debris, to prevent the inadvertent disposal of
a source into regular trash.
5. Return brachytherapy sources to the storage area promptly upon their
removal, and count the number returned to ensure that all sources taken
from storage have been returned as required by 10 CFR 35.406(a).
6. Maintain a record to include the number and activity of sources removed
date of removal and return, the number and activity of sources
remaining in storage after removal and return, and the initials of the
individuals who removed and returned the sources as described in 10 CFR
35.406(b)(2).
No specific written response is required by this information notice. If you
have any questions about this matter, please contact the appropriate
regional office or this office.
Richard Cunningham, Director
Division of Industrial and
Medical Nuclear Safety
Office of Nuclear Material Safety
and Safeguards
Technical Contact: Sally Merchant, NMSS
(301) 492-0637
Attachments:
1. List of Recently Issued NMSS
Information Notices.
2. List of Recently Issued NRC
Information Notices.
.
Page Last Reviewed/Updated Thursday, March 25, 2021